Thromb Haemost 1982; 48(03): 270-273
DOI: 10.1055/s-0038-1657278
Original Article
Schattauer GmbH Stuttgart

Common Units for Clotting Factors Assayed Against Different Standards

W R S North
The MRC Epidemiology and Medical Care Unit, Northwick Park Hospital, Harrow, Middx, U. K.
,
Y Stirling
The MRC Epidemiology and Medical Care Unit, Northwick Park Hospital, Harrow, Middx, U. K.
,
T W Meade
The MRC Epidemiology and Medical Care Unit, Northwick Park Hospital, Harrow, Middx, U. K.
› Author Affiliations
Further Information

Publication History

Received 12 March 1982

Accepted after revision 21 September 1982

Publication Date:
13 July 2018 (online)

Summary

There are no generally accepted units for clotting factors except factor VIII. Results are usually expressed as percentages of the standards used in the assays and standards vary in their potency. Over a six year period, factors V, VII and VIII were measured in over 3000 participants in the Northwick Park Heart Study. Six different standards had to be used. For comparative purposes, all results were expressed in terms of the first standard (71/11). This paper describes how appropriate conversion values were derived. Three different methods were compared. One consisted of the assay of each standard against its replacement. Another was based on the use of a reference plasma spanning the use of two successive standards. The third was a population-based, or epidemiological method using the data from all the participants in the study. This method is based on the assumption that results would be the same in comparable groups of study participants. In order to ensure comparability, personal characteristics which affect clotting factor levels, such as age and degree of obesity, were taken into account. The three methods gave similar results but the population method was, in general, the most satisfactory for factor VIII as well as factors V and VII, and has been adopted for routine use.

 
  • References

  • 1 Meade TW, North WRS. Population-based distribution of haemostatic variables. Br Med Bull 1977; 33: 283-288
  • 2 Meade TW, North WRS, Chakrabarti R, Stirling Y, Haines AP, Thompson SG. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; 1: 1050-1054
  • 3 Meade TW, Brozovic M, Chakrabarti R, Howarth DJ, North WRS, Stirling Y. An epidemiological study of the haemostatic and other effects of oral contraceptives. Br J Haematol 1976; 34: 353-364
  • 4 Brozovic M, Chakrabarti R, Stirling Y, Fenton S, North WRS, Meade TW. Factor V in an industrial population. Br J Haematol 1976; 33: 543-550
  • 5 Brozovic M, Stirling Y, Harricks C, North WRS, Meade TW. Factor VII in an industrial population. Br J Haematol 1974; 28: 381-391
  • 6 Stirling Y, Howarth DJ, Vickers M, North WRS, Meade TW. Automation of two-stage factor Vm assay. Thromb Haemostas 1978; 39: 455-465
  • 7 Barrowcliffe TW, Kirkwood TBL. Standardisation of factor VIII. I. Calibration of British Standards for factor VIII clotting activity. Br J Haematol 1980; 46: 471-481